Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026)
Tyra Biosciences' (TYRA) quarterly Retained Earnings came in at $107000.0 in Q1 2026, up 100.04% YoY from $53489.8 in Q1 2025, and up 100.03% on a QoQ basis from -$371.3 million in Q4 2025.
Tyra Biosciences (TYRA) Retained Earnings (2020 - 2026) Analysis & Trends
Tyra Biosciences (TYRA) has 7 years of Retained Earnings data on file, last reported at $107000.0 in Q1 2026.
- Quarterly Retained Earnings rose 100.04% year-over-year to $107000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107000.0 (up 100.04% YoY) and the FY2025 annual result came in at -$371.3 million, down 47.73% from the prior year.
- Retained Earnings grew to $107000.0 in Q1 2026, from -$371.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.8 million in Q3 2024 to a low of -$371.3 million in Q4 2025.
- A 5-year average of -$142.4 million and a median of -$107.6 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 101.23% — and 2025, when it slumped 4657533.33%.
- Tracing TYRA's Retained Earnings over 5 years: stood at -$95.7 million in 2022, then jumped by 100.4% to $381000.0 in 2023, then tumbled by 66060.89% to -$251.3 million in 2024, then plunged by 47.73% to -$371.3 million in 2025, then soared by 100.03% to $107000.0 in 2026.
- The last three Retained Earnings figures came in at $107000.0 (Q1 2026), -$371.3 million (Q4 2025), and -$337.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - | -456.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -456.12 Mn |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | -371.26 Mn |
| Sep 30, 2025 | -337.42 Mn |
| Jun 30, 2025 | -307.56 Mn |
| Mar 31, 2025 | -279.46 Mn |
| Dec 31, 2024 | -251.31 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | -201.72 Mn |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | -142.00 Mn |
| Jun 30, 2023 | -120.85 Mn |
| Mar 31, 2023 | -107.58 Mn |
| Dec 31, 2022 | -95.70 Mn |
| Sep 30, 2022 | -82.80 Mn |
| Jun 30, 2022 | -70.29 Mn |
| Mar 31, 2022 | -55.20 Mn |
| Dec 31, 2021 | -40.37 Mn |
| Sep 30, 2021 | -30.44 Mn |